KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iqvia Holdings (IQV) EBT (2016 - 2025)

Iqvia Holdings' EBT history spans 14 years, with the latest figure at $537.0 million for Q4 2025.

  • For Q4 2025, EBT fell 1.29% year-over-year to $537.0 million; the TTM value through Dec 2025 reached $1.6 billion, down 4.67%, while the annual FY2025 figure was $1.6 billion, 4.67% down from the prior year.
  • EBT for Q4 2025 was $537.0 million at Iqvia Holdings, up from $408.0 million in the prior quarter.
  • Across five years, EBT topped out at $544.0 million in Q4 2024 and bottomed at $222.0 million in Q2 2021.
  • The 5-year median for EBT is $354.5 million (2022), against an average of $360.5 million.
  • The largest annual shift saw EBT surged 988.0% in 2021 before it decreased 26.86% in 2022.
  • A 5-year view of EBT shows it stood at $376.0 million in 2021, then dropped by 26.86% to $275.0 million in 2022, then soared by 35.64% to $373.0 million in 2023, then surged by 45.84% to $544.0 million in 2024, then fell by 1.29% to $537.0 million in 2025.
  • Per Business Quant, the three most recent readings for IQV's EBT are $537.0 million (Q4 2025), $408.0 million (Q3 2025), and $323.0 million (Q2 2025).